NEW YORK (GenomeWeb) – Waters reported today that its first quarter revenues rose 7 percent year over year, as the company saw solid demand among its pharma customers but a decline in sales of its mass spectrometry instruments.

Waters posted revenues of $530.7 million for the quarter compared to $498 million in Q1 2017, below the average Wall Street estimate of $535.3 million.

Currency translation increased sales growth by around 5 percent, the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A University of California, Los Angeles-led team has found turning off the CCR5 gene could improve recovery after a stroke, according to Scientific American.

South Dakota lawmakers are to weigh a bill aimed at teaching the strengths and weaknesses of scientific concepts, the Associated Press and KEVN-Black Hills Fox report.

In Science this week: the synthetic genetic system hachimoji, and more.

Thermo Fisher Scientific says it will no longer sell machines in China's Xinjiang region, according to the Wall Street Journal.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost.